Showing results (211-220 of 307) with videos related to
Sort By:
Pageof 31
Rheumatology (Oxford, England)|November 24, 2020
Visceral adiposity in patients with psoriatic arthritis and psoriasis alone and its relationship with metabolic and cardiovascular riskEric Toussirot, François Aubin, Maxime Desmarets, et al.Human Vaccines & Immunotherapeutics|September 20, 2018
Treatment of active rheumatoid arthritis: comparison of patients younger vs older than 75 years (CORPUS cohort)Sachiyo Oishi, Daniel Wendling, Jean Sibilia, et al.RMD Open|March 1, 2024
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA studyMaxime Dougados, Audrey Lardy-Cléaud, Emilie Desfleurs, et al.RMD Open|May 13, 2020
5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohortQueeny Madari, Alexandre Sepriano, Sofia Ramiro, et al.Joint Bone Spine|January 14, 2014
Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritisDaniel Wendling, Cédric Lukas, Julien Paccou, et al.Joint Bone Spine|March 8, 2022
Systematic assessment of heart valves and cardiac function by echocardiography in axial spondyloarthritis: A systematic review and meta-analysisXavier Romand, Fanny Adeline, Mickael Dalecky, et al.Joint Bone Spine|April 6, 2025
Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATEJacques Morel, Amélie Wetzman, Daniel Wendling, et al.Rheumatology (Oxford, England)|May 16, 2021
Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abataceptClaire Rempenault, Cédric Lukas, Bernard Combe, et al.Arthritis and Rheumatism|May 4, 2011
Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritisAlain Meyer, Emmanuel Chatelus, Daniel Wendling, et al.Annals of the Rheumatic Diseases|August 6, 2016
Can we use structural lesions seen on MRI of the sacroiliac joints reliably for the classification of patients according to the ASAS axial spondyloarthritis criteria? Data from the DESIR cohortPauline A C Bakker, Rosaline van den Berg, Gregory Lenczner, et al.Pageof 31